Berlin, Friday 15 December 2017 09.05 GMT
Can digital therapeutic interventions empower multiple sclerosis (MS) patients to better cope with symptom flare-ups? Can digital therapy software help reduce inflammation? Can such solutions prevent relapses and improve quality of life?
To empower and support MS patients, GAIA has been commissioned to develop digital interventions that will be evaluated in randomized controlled trials.
MS is a degenerative disease of the central nervous system with no known cause or cure. It affects over 200,000 people in Germany.
This project is conducted in collaboration with leading global MS researchers and the German MS Society, among others.
Under the leadership of Professor C. Heesen at the University Medical Center Hamburg-Eppendorf (UKE), competitive grant funding was obtained from the Federal Joint Committee’s (G-BA) innovation funding scheme (“Innovationsfonds”).
We are proud to play a key role in this innovative project, which aims to improve the quality of care for people living with MS.